Glaxo settles U.S. drug pricing complaint
20th Sep 2005, 23:02 GMT
WASHINGTON (Reuters) - GlaxoSmithKline has paid more than $150 million to settle government charges that the company fraudulently inflated the price of drugs purchased by federal health-care programs, the U.S. Justice Department said on Tuesday.
Latest news from Reuters: Health:
- Blow to chest can be fatal in child athletes: study
- Two Canada professors win right to toke up at work
- Diabetes drug may cut heart risks: study
- Most U.S. women in the dark about HPV: survey
- Red meat linked to some breast cancers: study
- Weight-loss surgery safety varies drastically: study
- Flu shot linked to tiny rise in risk for ailment
- Human natural painkiller beats morphine: research
- Radioactive iodine linked to thyroid disease
- Children showing hardening of arteries: study